Travere Therapeutics (TVTX) Net Margin (QoQ) (2014 - 2026)

Travere Therapeutics (TVTX) Net Margin (QoQ) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Travere Therapeutics 5.21 Bn 5.21 Bn 125.25 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 663.00
Dec 31, 2024 7.00
Sep 30, 2024 131.00
Jun 30, 2024 -115.00
Mar 31, 2024 325.00
Dec 31, 2023 -65,042.00
Sep 30, 2023 59,629.00
Jun 30, 2023 1,750.00
Mar 31, 2023 -3,440.00
Dec 31, 2022 1,622.00
Sep 30, 2022 595.00
Jun 30, 2022 2,070.00
Mar 31, 2022 -3,143.00
Dec 31, 2021 10,834.00
Sep 30, 2021 1,918.00
Jun 30, 2021 4,220.00
Mar 31, 2021 12,493.00
Dec 31, 2020 -19,446.00
Sep 30, 2020 973.00
Jun 30, 2020 -5,557.00